Leo Ehrlich SEC EDGAR Filings (CIK 0001288099)

SEC EDGAR filings, ownership reports, and insider transactions for Leo Ehrlich.

Business address
C/O Innovation Pharmaceuticals Inc., 301 Edgewater Place Suite 100, Wakefield, MA, 01880
Get insider transactions for this reporting owner
Leo Ehrlich has filed 11 SEC EDGAR filings since 07 Jan 2005

Latest Filings

Recent SEC filings for Leo Ehrlich including 4, 5, 3 and more.

Form type Document Filing Description Filing date Reporting date File number(s)
4 Open 4 document View SEC filing for 4 FORM 4 04 Jan 2023 30 Dec 2022 001-37357
4 Open 4 document View SEC filing for 4 FORM 4 28 Sep 2022 23 Feb 2020 001-37357
4 Open 4 document View SEC filing for 4 FORM 4 01 Apr 2020 30 Mar 2020 001-37357
4 Open 4 document View SEC filing for 4 FORM 4 31 Jan 2019 29 Jan 2019 001-37357
5 Open 5 document View SEC filing for 5 FORM 5 08 Aug 2017 30 Jun 2017 001-37357
4 Open 4 document View SEC filing for 4 FORM 4 02 Jan 2015 30 Dec 2014 000-52321
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 07 Jan 2013 21 Dec 2012 000-52321
4 Open 4 document View SEC filing for 4 PRIMARY DOCUMENT 30 Jul 2012 27 Jul 2010 000-52321

About this filer

Leo Ehrlich files with the SEC under CIK 0001288099. This page aggregates EDGAR filings and related ownership activity.

See reporting owner transactions.

FAQ

What is a CIK?
A Central Index Key (CIK) is a unique identifier assigned by the SEC to each filer.
Why are some filings missing?
New filings appear as the SEC updates EDGAR, and older records can vary by availability.
How often is this page updated?
Updates follow new EDGAR submissions and periodic data refreshes.

Related pages